93 related articles for article (PubMed ID: 8018740)
1. Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting.
Kell MJ
J Addict Dis; 1994; 13(1):5-26. PubMed ID: 8018740
[TBL] [Abstract][Full Text] [Related]
2. Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients: II. Generation of plasma concentration response curves.
Kell MJ
J Addict Dis; 1995; 14(1):85-108. PubMed ID: 7632750
[TBL] [Abstract][Full Text] [Related]
3. The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
Borg L; Ho A; Wells A; Joseph H; Appel P; Moody D; Kreek MJ
J Addict Dis; 2002; 21(3):13-22. PubMed ID: 12094997
[TBL] [Abstract][Full Text] [Related]
4. Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations.
Tennant F; Shannon J
J Addict Dis; 1995; 14(1):67-74. PubMed ID: 7632748
[TBL] [Abstract][Full Text] [Related]
5. Methadone maintenance: optimizing dosage by estimating plasma level.
Dole VP
J Addict Dis; 1994; 13(1):1-4. PubMed ID: 8018735
[No Abstract] [Full Text] [Related]
6. [Individual dosing in methadone substitution therapy. Determination of concentration with high performance liquid chromatography in comparison to immunoassay].
Loimer N; Schmid R; Rauch B
Arzneimittelforschung; 1992 Nov; 42(11):1346-9. PubMed ID: 1492849
[TBL] [Abstract][Full Text] [Related]
7. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
[TBL] [Abstract][Full Text] [Related]
8. Altered methadone pharmacokinetics in pregnancy: implications for dosing.
Swift RM; Dudley M; DePetrillo P; Camara P; Griffiths W
J Subst Abuse; 1989; 1(4):453-60. PubMed ID: 2485290
[TBL] [Abstract][Full Text] [Related]
9. [Methadone blood assay by the FPIA technique: application to the monitoring of patients in maintenance treatment to opiates].
Boglione-Kerrien C; Furet Y; Bachellier J; Paintaud G; Autret-Leca E
Ann Biol Clin (Paris); 2007; 65(1):51-7. PubMed ID: 17264039
[TBL] [Abstract][Full Text] [Related]
10. Craving despite extremely high methadone dosage.
de Vos JW; Ufkes JG; van Brussel GH; van den Brink W
Drug Alcohol Depend; 1996 Mar; 40(3):181-4. PubMed ID: 8861396
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of interim methadone maintenance.
Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
[TBL] [Abstract][Full Text] [Related]
12. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
13. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
Dyer KR; Foster DJ; White JM; Somogyi AA; Menelaou A; Bochner F
Clin Pharmacol Ther; 1999 Jun; 65(6):685-94. PubMed ID: 10391674
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of plasma methadone: intercorrelation between immunoassay and gas chromatography-mass spectrometry.
Beck O; Boreus LO; Borg S; Jacobsson G; Lafolie P; Stensiö M
Ther Drug Monit; 1990 Sep; 12(5):473-7. PubMed ID: 2293410
[TBL] [Abstract][Full Text] [Related]
15. Non-prescribed drug use during methadone treatment by clinic- and community-based patients.
Wolff K; Hay AW; Vail A; Harrison K; Raistrick D
Addiction; 1996 Nov; 91(11):1699-704. PubMed ID: 8972927
[TBL] [Abstract][Full Text] [Related]
16. Rapid measurement of plasma methadone in a clinical setting using florescence polarization immunoassay.
Kell MJ; Techman T
J Addict Dis; 1996; 15(2):69-83. PubMed ID: 8704002
[TBL] [Abstract][Full Text] [Related]
17. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
Subst Alcohol Actions Misuse; 1983; 4(5):369-74. PubMed ID: 6670059
[TBL] [Abstract][Full Text] [Related]
18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
19. When "enough" is not enough: new perspectives on optimal methadone maintenance dose.
Leavitt SB; Shinderman M; Maxwell S; Eap CB; Paris P
Mt Sinai J Med; 2000; 67(5-6):404-11. PubMed ID: 11064491
[TBL] [Abstract][Full Text] [Related]
20. Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status.
Anglin MD; Conner BT; Annon J; Longshore D
Addiction; 2007 Sep; 102(9):1432-42. PubMed ID: 17697277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
